HANNAH A VALANTINE plan to sell securities of BRIDGEBIO PHARMA, INC. under Form 144

HANNAH A VALANTINE filed Form 144 to notify SEC of plan to sell 2196 units of BRIDGEBIO PHARMA, INC. securities around 2026-06-23, with aggregate market value of $150,579.72. The total outstanding units is 195861242.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months include: On 06/22/2026, sold 2808 units for $190944.00;